← Open Payments lookup

GINGER MCDANIEL: Open Payments

NPI 1477889590 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,423 in 108 payments from 16 companies in 2025. Trend: 2023 $6,027 · 2024 $8,022 · 2025 $9,423

Speaker / faculty: $6,865Food & beverage: $2,106Travel & lodging: $354Education: $99
CompanyPaymentsAmount
ABBVIE INC.22$5,777
Phathom Pharmaceuticals, Inc.6$1,887
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$315
PFIZER INC.16$249
Janssen Biotech, Inc.7$224
Takeda Pharmaceuticals U.S.A., Inc.7$221
Ardelyx, Inc.9$182
Madrigal Pharmaceuticals9$177
Celltrion USA Inc.5$108
Gilead Sciences, Inc.1$80

Products named: LINZESS, VOQUEZNA, XIFAXAN, TREMFYA, ENTYVIO, XELJANZ, IBSRELA, REZDIFFRA.

Industry payments across AL — which companies pay providers there.